BFEC
NYMX

Benjamin F. Edwards & Company’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Benjamin F. Edwards & Company’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,008
Closed -$16K – 952
2014
Q1 		$16K Buy
+3,008
New +$17.5K ﹤0.01% 623

Other funds holding NYMX

AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Benjamin F. Edwards & Company's NYMX Position: Q2 2014 in Review

Benjamin F. Edwards & Company sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2014, closing a stake of 3,008 shares — an estimated $16K sold.

Benjamin F. Edwards & Company first reported a position in NYMX in Q1 2014 and held it in 1 quarter. The position peaked at $16K in Q1 2014. 31 funds tracked by Wall St. Rank hold NYMX as of Q2 2014.

  • Benjamin F. Edwards & Company reported no remaining Nymox Pharmaceutical Corp position as of Q2 2014 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 3,008 Nymox Pharmaceutical Corp shares in Q2 2014, an estimated $16K.
  • Benjamin F. Edwards & Company first reported a position in Nymox Pharmaceutical Corp in Q1 2014 and held it in 1 quarter.
  • Benjamin F. Edwards & Company's Nymox Pharmaceutical Corp position peaked at $16K in Q1 2014.
  • 31 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2014.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2014, filed 21 Jul 2014.